This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at bakerdan@wsu.edu.
Comparative agents: None
Indication:
Combination with 5-fluorouracil, leucovorin, irinotecan (FOLFIRI) is indicated for patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen
Mechanism of action:
Soluble receptor that binds to human vascular endothelial growth factor (VEGF)-A and VEGF-B and to human placenta growth factor-1 (PlGF). By binding to these endogenous ligands, it inhibits the binding and activation of their cognate receptors and decreases the rate of neovascularization and vascular permeability. Epinephrine auto-injector with audio and visual cues that guide the patient and caregiver step-by-step through the injection process; drug is approved for the emergency treatment of life-threatening allergic reactions.
New indications
Emtricitabine / tenofovir disoproxil fumarate
In combination with safer sex practices for preexposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults at high risk
Everolimus
Afinitor ( 
